Penumbra Inc (PEN) : Carret Asset Management added new position in Penumbra Inc during the most recent quarter end. The investment management firm now holds 544,720 shares of Penumbra Inc which is valued at $40,472,696 , the company said in a statement filed on Aug 10, 2016 with the SEC.Penumbra Inc makes up approximately 7.45% of Carret Asset Management’s portfolio.
Other Hedge Funds, Including , Glenmede Trust Co Na added PEN to its portfolio by purchasing 190 company shares during the most recent quarter which is valued at $12,675.Regis Management Co boosted its stake in PEN in the latest quarter, The investment management firm added 20,104 additional shares and now holds a total of 65,606 shares of Penumbra Inc which is valued at $4,409,379. Penumbra Inc makes up approx 0.87% of Regis Management Co’s portfolio. Quantbot Technologies Lp added PEN to its portfolio by purchasing 2,550 company shares during the most recent quarter which is valued at $171,386. Penumbra Inc makes up approx 0.02% of Quantbot Technologies Lp’s portfolio. Old Mutual Global Investors (uk) Ltd. added PEN to its portfolio by purchasing 16,905 company shares during the most recent quarter which is valued at $1,021,231. Penumbra Inc makes up approx 0.02% of Old Mutual Global Investors (uk) Ltd.’s portfolio.
On the company’s financial health, Penumbra Inc reported $0.01 EPS for the quarter, beating the analyst consensus estimate by $ 0.08 according to the earnings call on Aug 9, 2016. Analyst had a consensus of $-0.07. The company had revenue of $65.10 million for the quarter, compared to analysts expectations of $58.18 million. The company’s revenue was up 53.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.11 EPS.
Penumbra Inc. is an interventional therapies company that designs develops manufactures and markets medical devices. The Company has a portfolio of products that addresses medical conditions and clinical needs across two markets which includes neuro and peripheral vascular. Its neuro products include Neurovascular Access Neuron Access System BENCHMARK Intracranial Access System Penumbra System 3D Penumbra Coil 400 Penumbra SMART Coil and LIBERTY stent. The Companys neuro surgical tools include Apollo System. Its peripheral vascular products include Ruby Coil System Penumbra Occlusion Device (POD) and Indigo System. Its products address conditions which include ischemic stroke and hemorrhagic stroke which involve blockage or rupture of blood vessels in the brain and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures which involve the use of medical devices to remove or treat blockages or ruptures of blood vessels.